Journal Article DKFZ-2024-02168

http://join2-wiki.gsi.de/foswiki/pub/Main/Artwork/join2_logo100x88.png
Development of a novel immunocompetent murine tumor model for urothelial carcinoma using in vivo electroporation.

 ;  ;  ;  ;  ;  ;

2024
Macmillan Publishers Limited, part of Springer Nature [London]

Scientific reports 14(1), 25619 () [10.1038/s41598-024-77178-z]
 GO

This record in other databases:

Please use a persistent id in citations: doi:

Abstract: A lack of advanced preclinical mouse tumor models impedes the progress in urothelial carcinoma research. We present here a novel fast, robust, reliable, and highly reproducible model for the genetic induction of bladder cancer in immunocompetent mice. Different sets of oncogenic transposons (Cmyc, Kras) and Cre drivers were transfected into the murine bladder wall of two different genetic backgrounds (Trp53fl/fl and BrafV600E, Ptenfl/fl, Ctnnb1exon3-fl/fl). Transfection was carried out using in vivo electroporation of the bladder after surgical exploration and transmural or transurethral intravesical plasmid injection. Up to 100% of animals developed urothelial carcinomas of the bladder. Time to tumor onset ranged from 16 to 97 days with a median of approximately 23 days in the fastest groups. Histological examination identified orthotopic urothelial carcinomas in most cases, in some experimental groups up to 100%. The resulting tumors were highly invasive and often metastatic. Metastases were found in up to 100% of tumor bearing mice per group. Taken together, this study establishes the proof-of-principle that in vivo electroporation can be versatilely employed as a reliable, fast, and robust method for the highly reproducible induction of urothelial carcinomas in the murine bladder wall. This novel murine tumor model could pave the way towards more easily modelling subtype specific urothelial carcinomas in mice.

Keyword(s): Animals (MeSH) ; Electroporation: methods (MeSH) ; Mice (MeSH) ; Urinary Bladder Neoplasms: pathology (MeSH) ; Urinary Bladder Neoplasms: genetics (MeSH) ; Disease Models, Animal (MeSH) ; Female (MeSH) ; Carcinoma, Transitional Cell: pathology (MeSH) ; Carcinoma, Transitional Cell: genetics (MeSH)

Classification:

Note: #EA:A190#LA:A190#

Contributing Institute(s):
  1. A190 Vaskuläre Onkologie und Metastasierung (A190)
Research Program(s):
  1. 311 - Zellbiologie und Tumorbiologie (POF4-311) (POF4-311)

Appears in the scientific report 2024
Database coverage:
Medline ; Creative Commons Attribution CC BY (No Version) ; DOAJ ; Article Processing Charges ; BIOSIS Previews ; Biological Abstracts ; Clarivate Analytics Master Journal List ; Current Contents - Physical, Chemical and Earth Sciences ; DOAJ Seal ; Ebsco Academic Search ; Essential Science Indicators ; Fees ; IF < 5 ; JCR ; PubMed Central ; SCOPUS ; Science Citation Index Expanded ; Web of Science Core Collection ; Zoological Record
Click to display QR Code for this record

The record appears in these collections:
Document types > Articles > Journal Article
Public records
Publication Charges
Publications database

 Record created 2024-10-28, last modified 2025-02-20



Rate this document:

Rate this document:
1
2
3
 
(Not yet reviewed)